JPRN-UMIN000020363已完成未知
An investigator initiated phase II clinical trial of Tamibarotene (AM80G) for chronic graft-versus-host disease - A phase II trial of Tamibarotene administration for Chronic GVHD
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 18
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Mental illness which needs psychiatric medication or are judged by physician as being unsuitable 2. Active, uncontrolled infection (not responding to antibiotics, antifungal or antiviral therapies) 3. Patients with severe liver dysfunction (CTCAE ver.4.0 Grade 3 or more, excepting liver GVHD) 4. Patients with previous experience with Am80 or other retinoid in the past 12 weeks 5. Patients who are allergic or hypersensitive to Am80 or other retinoid. 6. Patients who are pregnant, patients who have possibility of being pregnant, or patients who are breastfeeding. 7. Pulmonary: DLCO <40% or FEV1% <40% 8. Patients with life expectancy of less than 6 months. 9. Patients who are enrolled in other clinical studies in the past 3 months. 10. Other patients who are judged by physician as being unsuitable
研究者
相似试验
进行中（未招募）
2 期
An investigator-initiated, phase II clinical trial of the peptide-based cancer vaccine targeting WT1, DSP-7888, for colorectal adenomas in familial adenomatous polyposisFAPfamilial adenomatous polyposisJPRN-jRCT2051200082Shichijo Satoki30
招募中
2 期
Investigator-initiated clinical trial (Phase II) of cancer vaccine DSP-7888 for acute myeloid leukemia patients.Acute myeloid leukemiaD015470AMLJPRN-jRCT2051200023akata Jun100
进行中（未招募）
2 期
Investigator-initiated phase II trial to evaluate the efficacy and safety of Acotiamide in patients with esophagogastric junction outflow obstructioJPRN-jRCT2071210072Ihara Eikichi42
进行中（未招募）
2 期
Phase II multicenter investigator initiated trial of Convection-enhanced delivery of Nimustine Hydrochloride against brainstem gliomasJPRN-jRCT2021190003Tominaga Teiji30
招募中
2 期
An investigator-initiated clinical trial of TM5614 for SSc-ILDInterstitial lung disease associated with systemic sclerosisD012595JPRN-jRCT2021230022Asano Yoshihide50